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Introduction
The prevalence of myocardial fibrosis among patients
with idiopathic dilated cardiomyopathy (IDCM), as
detected by the late-gadolinium cardiac magnetic reso-
nance (LG-CMR) technique, is reported to be 28-42% in
highly-selected samples from specialist heart failure clin-
ics. The presence of fibrosis has been demonstrated to pre-
dict the incidence of major adverse cardiovascular events.
However, as the heart failure duration prior to first CMR
imaging in these studies was at least 12 months the prev-
alence of myocardial fibrosis at presentation is unknown.
Moreover, the determinants of the response-to-therapy of
newly diagnosed IDCM patients have not been character-
ised using CMR and advanced echocardiographic tech-
niques.
Purpose
1. To determine the prevalence of myocardial fibrosis
using the LG-CMR technique among newly diagnosed idi-
opathic dilated cardiomyopathy IDCM patients present-
ing to a tertiary hospital setting. 2.To characterise cardiac
remodelling and functional changes following medical
therapy for IDCM.
Methods
Forty-five consecutive patients were studied, a median of
14 days (inter-quartile range 7-23 days) and 30 weeks (22-
33 weeks) after newly diagnosed IDCM. Coronary disease
was excluded by angiography. All subjects underwent cine
CMR for global and regional systolic functional assess-
ment, T2-weighted inversion-recovery sequences for myo-
cardial oedema (to exclude myocarditis) and LG-CMR for
assessment of myocardial fibrosis. Additionally, subjects
underwent echocardiography for evaluation of LV diasto-
lic function and dyssynchrony (as measured by the radial
and longitudinal strain dyssynchrony indices). Functional
assessment was undertaken using cardiopulmonary exer-
cise testing, 6-minute walk test, and Minnesota Living
With Heart Failure Questionnaire.
Results
Late-gadolinium enhancement was present in eight
(18%) subjects at presentation. There was significant
improvement in LV and RV systolic function, LV remodel-
ling, LV diastolic function, left atrial function and remod-
elling following therapy (Table 1). Advancing age was the
only predictor of poor response in LV systolic function
with therapy (r2 = 0.22, p = 0.04), whereas late-gadolin-
ium enhancement, LV eccentricity, and VO2 MAX did not.
The more dyssynchronous the LV the greater the reduction
in LV mass following medical therapy (longitudinal strain
dyssynchrony index: r2 = 0.28, p = 0.02; radial strain dys-
synchrony index r2 = 0.32, p = 0.02).
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This study demonstrates for the first time a moderate prev-
alence of myocardial fibrosis at diagnosis of IDCM - less
than in series of established IDCM. This may reflect delays
to presentation owing to the insidious nature of symp-
toms. LV dyssynchrony portends favourable cardiac
remodelling with pharmacotherapy, extending observa-
tions from cardiac resynchronisation literature.
Table 1: 
Parameter Baseline Follow-up P-value
CMR
LV ejection fraction ± SD (%) 27 ± 9 45 ± 10 <0.001
LV end-systolic volume ± SD (mL) 120 ± 42 93 ± 46 0.004
LV end-diastolic volume ± SD (mL) 167 ± 45 155 ± 53 0.1
LV mass ± SD (g) 158 ± 39 147 ± 34 0.004
LV eccentricity index (LV mass/LVEDV) ± SD (g/mL) 0.64 ± 0.13 0.76 ± 0.17 0.03
RV ejection fraction ± SD (%) 46 ± 15 60 ± 9 0.004
RV end-diastolic volume ± SD (mL) 79 ± 38 60 ± 32 0.2
RV end-systolic volume ± SD (mL) 143 ± 42 140 ± 47 0.4
Echocardiographic
LA volume ± SD (mL) 97 ± 30 73 ± 26 0.002
LA strain ± SD (%) 12 ± 6 19 ± 6 0.02
E/A ratio 1.4 ± 0.9 0.9 ± 0.4 0.04
Diastolic grade ± SD 2.4 ± 1.1 1.3 ± 0.8 0.002
Functional
Heart rate ± SD (bpm) 80 ± 17 64 ± 13 <0.001
6-MWD ± SD (m) 421 ± 103 483 ± 85 0.07
VO2 MAX ± SD (mL/kg/min) 20 ± 5 21 ± 5 0.7
MLWHF score 40 ± 19 30 ± 21 0.13Page 2 of 2
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